Recent Updates
Recently added Catalysts
EHTH Positive Sentiment Score: 85/100

Document eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2024 Results Reports record-high total revenue and net income quarter in Company's history Outperforms FY'24 revenue and profitability guidance driven by 42

Key Takeaway: eHealth, Inc. has reported its Q4 and fiscal year 2024 results, attaining record-high total revenue of $315.2 million, a 27% increase from Q4 2023. The company also experienced an 87% rise in GAAP net income, reaching $97.5 million, and noted significant growth in Medicare submissions and approved members. For 2025, eHealth forecasts total revenue between $510 million to $550 million, amid a constantly evolving market landscape. Despite the strong performance, the company acknowledges the potential risks associated with future operational challenges and market dynamics.

Market Sentiment Analysis

POSITIVE FACTORS

  • Record-high total revenue and net income reported in Q4 2024.
  • 42% growth in Medicare Advantage submissions showcased strong market performance.
  • Adjusted EBITDA improved significantly, indicating operational efficiency.

Full Press Release Details

eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2024 Results
Reports record-high total revenue and net income quarter in Company's history
Outperforms FY'24 revenue and profitability guidance driven by 42% growth in Medicare Advantage submissions and 16% Medicare unit margin expansion in fourth quarter
Ends FY'24 with highest ever commissions receivable balance of $1.0 billion
AUSTIN, Texas - February 26, 2025 - eHealth, Inc. (Nasdaq EHTH), a leading private online health insurance marketplace, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2024.
CEO Comments
"eHealth delivered outstanding fourth quarter results materially exceeding our expectations for enrollment volumes, revenue, and earnings. We gained share in the Medicare Advantage market while also meaningfully expanding our Medicare enrollment margins. This is a testament to the success of the transformed eHealth, including the strong performance of our licensed agents, our innovative omnichannel platform and the growing prominence of our brand. In addition to the remarkable execution of our operating teams, these results reflect unique Medicare market dynamics, which made the value proposition of our carrier-agnostic choice platform more relevant than ever." - Fran Soistman, Chief Executive Officer
Q4 2024 total Medicare submissions(a) across our core agency and carrier-dedicated Amplify platforms grew 38% compared to Q4 2023, driven primarily by Medicare Advantage ("MA") submissions growth of 42% year-over-year.
Q4 2024 total Medicare approved members increased 33% year-over-year, driven mostly by a 39% increase in Q4 2024 MA approved members year-over-year.
Q4 2024 total revenue of $315.2 million increased 27% compared to Q4 2023 total revenue of $247.7 million, driven primarily by meaningful Medicare segment growth year-over-year, partially offset by lower positive net adjustment revenue.
Q4 2024 positive net adjustment revenue of $7.6 million compared to $15.6 million in Q4 2023.
Q4 2024 Non-GAAP total revenue excluding net adjustment revenue(1) increased $75.5 million, or 33%, year-over-year.
Q4 2024 Medicare unit margin expansion of 16%, year-over-year primarily driven by
a 23% decline in total acquisition cost per MA-equivalent approved member as a result of enhanced lead quality and significantly higher conversions, and
a 2% increase in MA constrained lifetime value ("LTV") of commissions.
Q4 2024 GAAP net income of $97.5 million increased 87% compared to Q4 2023 GAAP net income of $52.2 million.
Q4 2024 Non-GAAP net income(1) of $91.8 million, which excludes the post-tax impact of positive net adjustment revenue and asset impairment charges, improved $51.4 million, or 127%, year-over-year.
Q4 2024 adjusted EBITDA(1) of $121.3 million improved 74% compared to adjusted EBITDA(1) of $69.6 million in Q4 2023.
Q4 2024 adjusted EBITDA excluding net adjustment revenue(1) improved $59.7 million, or 110%, year-over-year, driven primarily by MA approved member growth, improved Medicare acquisition costs and continued fixed cost reduction efforts.
FY 2024 total Medicare submissions across our core agency and carrier-dedicated Amplify platforms grew 29% year-over-year.
FY 2024 total Medicare approved members grew 21% year-over-year.
FY 2024 total revenue of $532.4 million increased 18% compared to FY 2023 total revenue of $452.9 million.
FY 2024 net income of $10.1 million increased 136% compared to FY 2023 net loss of $28.2 million.
FY 2024 adjusted EBITDA(1) of $69.3 million increased significantly compared to FY 2023 adjusted EBITDA(1) of $14.1 million.
Commissions receivable balance of $1.0 billion as of December 31, 2024 grew 9% compared to $918.2 million as of December 31, 2023.
Note See the tables at the end of this press release for a reconciliation of our GAAP financial measures to our non-GAAP financial measures for the relevant periods and footnote (1) on page 15 at the end of this press release for definitions of our non-GAAP financial measures.
(a) Submissions describe applications that are submitted by individuals online through our eHealth platform or completed with the assistance of our benefit advisors where the individual provides authorization to the benefit advisor to submit the application to the insurance carrier partner. The individual may have additional actions to take before the application will be reviewed by the insurance carrier and not all submissions ultimately become approved members.
Based on information available as of February 26, 2025, we are providing guidance for the full year ending December 31, 2025. These expectations are forward-looking statements and we assume no obligation to update these statements. Actual results may be materially different and are affected by the risk factors and uncertainties identified in this press release and in eHealth's annual and quarterly reports filed with the Securities and Exchange Commission.
"Our guidance ranges reflect the dynamic nature of our sector. It is important to note that while 2024 was somewhat of an outlier in terms of market environment and resulting performance, our underlying trajectory remains strong, reflecting the operational improvements we have made. We are tracking ahead of the three-year financial targets that we provided in May of last year. Based on the mid-points of our 2025 guidance ranges, our 23-25 revenue CAGR is expected to be 8% with an implied 2025 adjusted EBITDA margin(1) of 9%. It also implies an impressive adjusted EBITDA(1) CAGR of 84%."- John Dolan, Chief Financial Officer
The following guidance is for the full year ending December 31, 2025
Total revenue is expected to be in the range of $510.0 million to $550.0 million.
GAAP net income (loss) is expected to be in the range of $(10.0) million to $15.0 million.
Adjusted EBITDA(1) is expected to be in the range of $35.0 million to $60.0 million.
Operating cash flow is expected to be in the range of $(25.0) million to $10.0 million.
The above guidance includes the expected impact of positive net adjustment revenue in the range of $0 to $20 million.
Note See accompanying footnotes on page 15.
Webcast and Conference Call Information
A webcast and conference call will be held today, Wednesday, February 26, 2025 at 8 30 a.m. Eastern Time 7 30 a.m. Central Time. Individuals interested in listening to the conference call may do so by dialing (800) 549-8228. The participant passcode is 72156. The live and archived webcast of the call will also be available under "Events Presentations" on the Investor Relations page of our website at https ir.ehealthinsurance.com.
We're Matchmakers. For over 25 years, eHealth has helped millions of Americans find the healthcare coverage that fits their needs at a price they can afford. As a leading independent licensed insurance agency and advisor, eHealth offers access to over 180 health insurers, including national and regional companies.
Forward-Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding our expectations regarding 2025 annual guidance for total revenue, GAAP net income (loss), adjusted EBITDA and operating cash flow our estimates for positive net adjustment revenue and its expected impact on our 2025 annual guidance and other statements regarding our future operations, financial condition, prospects and business strategies.
These forward-looking statements are inherently subject to various risks and uncertainties that could cause actual results to differ materially from the statements made. In particular, we are required by Accounting Standards Codification 606 - Revenue from Contracts with Customers to make numerous assumptions that are based on historical trends and our
management's judgment. These assumptions may change over time and have a material impact on our revenue recognition, guidance, and results of operations. Please review the assumptions stated in this press release carefully.
The risks and uncertainties that could cause our results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, our ability to retain existing members and enroll new members during the annual healthcare open enrollment period, the Medicare annual enrollment period, the Medicare Advantage open enrollment period and other special enrollment periods changes in laws, regulations and guidelines, including in connection with healthcare reform or with respect to the marketing and sale of Medicare plans competition, including competition from government-run health insurance exchanges and other sources the seasonality of our business and the fluctuation of our operating results our ability to accurately estimate membership, lifetime value of commissions and commissions receivable changes in product offerings among carriers on our ecommerce platform and changes in our estimated conversion rate of an approved member to a paying member and the resulting impact of each on our commission revenue the concentration of our revenue with a small number of health insurance carriers our ability to execute on our growth strategy and other business initiatives changes in our senior management or other key employees our ability to recruit, train, retain and ensure the productivity of licensed insurance agents, or benefit advisors, and other personnel exposure to security risks and our ability to safeguard the security and privacy of confidential data our relationships with health insurance carriers the success of our carrier advertising and sponsorship program our success in marketing and selling health insurance plans and our unit cost of acquisition our ability to effectively manage our operations as our business evolves and execute on our business plan and other strategic initiatives the need for health insurance carrier and regulatory approvals in connection with the marketing of Medicare-related insurance products changes in the market for private health insurance consumer satisfaction of our service and actions we take to improve the quality of enrollments changes in member conversion rates changes in commission rates our ability to sell qualified health insurance plans to subsidy-eligible individuals and to enroll subsidy-eligible individuals through government-run health insurance exchanges our ability to derive desired benefits from investments in our business, including membership growth and retention initiatives our reliance on marketing partners the success and cost of our marketing efforts, including branding, online advertising, direct-to-consumer mail, email, social media, telephone, SMS text, television, radio and other marketing efforts timing of receipt and accuracy of commission reports payment practices of health insurance carriers dependence on our operations in China the restrictions in our debt obligations the restrictions in our investment agreement with our convertible preferred stock investor our ability to raise additional capital compliance with insurance, privacy, cybersecurity and other laws and regulations the outcome of litigation or government enforcement actions in which we may from time to time be involved the performance, reliability and availability of our information technology systems, ecommerce platform and underlying network infrastructure, including any new systems we may implement our ability to deploy new and evolving technologies, such as artificial intelligence public health crises, pandemics, natural disasters and other extreme events general economic and macroeconomic conditions, including inflation, recession, political events, instability or geopolitical tensions, trade or other international disputes, financial, banking and credit market disruptions our ability to effectively administer our self-insurance program and other risks and uncertainties related to our business. Other factors that could cause our operating, financial and other results to differ are described in our most recent Quarterly Report on Form 10-Q or Annual Report on Form 10-K filed with the Securities and Exchange Commission and available on the Investor Relations page of our website at https ir.ehealthinsurance.com and on the Securities and Exchange Commission's website at www.sec.gov.
All forward-looking statements in this press release are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.
Investor Relations Contact
Kate Sidorovich, CFA
Senior Vice President, Investor Relations Strategy
investors ehealth.com
https ir.ehealthinsurance.com
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, unaudited)
December 31, 2024 December 31, 2023
Assets
Current assets
Cash and cash equivalents $ 39,197 $ 115,722
Short-term marketable securities 43,043 5,930
Accounts receivable 16,807 3,993
Contract assets - commissions receivable - current 242,467 244,663
Prepaid expenses and other current assets 12,961 12,044
Total current assets 354,475 382,352
Contract assets - commissions receivable - non-current 757,523 673,514
Property and equipment, net 4,437 4,864
Operating lease right-of-use assets 12,081 22,767
Restricted cash 3,090 3,090
Other assets 23,819 26,758
Total assets $ 1,155,425 $ 1,113,345
Liabilities, convertible preferred stock and stockholders' equity
Current liabilities
Accounts payable $ 23,448 $ 7,197
Accrued compensation and benefits 43,888 40,800
Accrued marketing expenses 16,612 20,340
Lease liabilities - current 7,732 7,070
Other current liabilities 4,331 3,131
Total current liabilities 96,011 78,538
Long-term debt 68,458 67,754
Deferred income taxes - non-current 38,870 29,687
Lease liabilities - non-current 20,731 28,333
Other non-current liabilities 5,418 4,949
Total liabilities 229,488 209,261
Convertible preferred stock 337,509 298,053
Stockholders' equity
Common stock 43 41
Additional paid-in capital 773,371 798,786
Treasury stock, at cost (199,998) (199,998)
Retained earnings 15,246 7,284
Accumulated other comprehensive loss (234) (82)
Total stockholders' equity 588,428 606,031
Total liabilities, convertible preferred stock and stockholders' equity $ 1,155,425 $ 1,113,345
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts, unaudited)
Three Months Ended December 31, Year Ended December 31,
2024 2023 % Change 2024 2023 % Change
Revenue
Commission $ 275,651 $ 218,496 26 % $ 461,647 $ 403,924 14 %
Other 39,530 29,166 36 % 70,763 48,947 45 %
Total revenue 315,181 247,662 27 % 532,410 452,871 18 %
Operating costs and expenses (a)
Cost of revenue 1,249 1,109 13 % 1,794 1,771 1 %
Marketing and advertising (8) 96,197 87,959 9 % 190,837 172,640 11 %
Customer care and enrollment (8) 62,675 55,611 13 % 163,448 149,562 9 %
Technology and content (8) 14,907 16,562 (10) % 53,520 58,609 (9) %
General and administrative (8) 27,447 27,053 1 % 89,765 99,363 (10) %
Impairment, restructuring and other charges 66 - * 9,475 - *
Total operating costs and expenses 202,541 188,294 8 % 508,839 481,945 6 %
Income (loss) from operations 112,640 59,368 90 % 23,571 (29,074) 181 %
Interest expense (2,642) (2,852) 7 % (11,159) (10,974) (2) %
Other income, net 475 1,953 (76) % 6,900 9,453 (27) %
Income (loss) before income taxes 110,473 58,469 89 % 19,312 (30,595) 163 %
Provision for (benefit from) income taxes 12,991 6,279 9,255 (2,381)
Net income (loss) 97,482 52,190 87 % 10,057 (28,214) 136 %
Preferred stock dividends (5,646) (5,321) (22,249) (20,965)
Change in preferred stock redemption value (6,149) (5,178) (22,768) (17,336)
Net income (loss) attributable to common stockholders $ 85,687 $ 41,691 106 % $ (34,960) $ (66,515) 47 %
Net income (loss) per share attributable to common stockholders (9)
Basic $ 2.57 $ 1.31 120 % $ (1.19) $ (2.37) 50 %
Diluted $ 2.51 $ 1.27 121 % $ (1.19) $ (2.37) 50 %
Weighted-average number of shares used in per share
Basic 29,706 28,469 4 % 29,335 28,016 5 %
Diluted 30,554 29,370 4 % 29,335 28,016 5 %
_____________________________ (a) Includes stock-based compensation expense as follows
Marketing and advertising $ 621 $ 603 $ 2,413 $ 2,201
Customer care and enrollment 358 58 1,845 2,287
Technology and content 733 1,114 3,331 4,498
General and administrative 3,044 3,697 12,292 14,227
Total stock-based compensation expense $ 4,756 $ 5,472 (13) % $ 19,881 $ 23,213 (14) %
Non-GAAP Results (1)
Adjusted EBITDA (1) $ 121,289 $ 69,615 74 % $ 69,265 $ 14,055 393 %
Adjusted EBITDA margin (1) 38 % 28 % 13 % 3 %
* Percentage calculated is not meaningful.
Note See accompanying footnotes on page 15.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
Three Months Ended December 31, Year Ended December 31,
2024 2023 2024 2023
Operating activities
Net income (loss) $ 97,482 $ 52,190 $ 10,057 $ (28,214)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Depreciation and amortization 502 632 1,983 2,540
Amortization of internally developed software 3,325 4,143 14,355 17,376
Stock-based compensation expense 4,756 5,472 19,881 23,213
Deferred income taxes 13,523 6,639 9,183 (2,672)
Impairment charges 66 - 7,479 -
Other non-cash items 472 696 429 701
Changes in operating assets and liabilities
Accounts receivable (10,943) (3,471) (12,814) (1,361)
Contract assets - commissions receivable (186,499) (137,754) (81,917) (33,594)
Prepaid expenses and other assets 5,690 10,649 (4,206) (1,948)
Accounts payable 18,138 306 16,173 487
Accrued compensation and benefits 17,680 14,008 3,087 20,110
Accrued marketing expenses 7,404 12,917 (3,728) (3,430)
Deferred revenue 550 (45) 1,411 1,278
Accrued expenses and other liabilities 192 232 261 (1,178)
Net cash used in operating activities (27,662) (33,386) (18,366) (6,692)
Investing activities
Capitalized internal-use software and website development costs (2,692) (1,665) (10,762) (8,693)
Purchases of property and equipment and other assets (631) (327) (2,094) (2,086)
Purchases of marketable securities (11,105) (5,912) (96,985) (54,514)
Proceeds from redemption and maturities of marketable securities 22,420 8,500 61,420 49,400
Net cash provided by (used in) investing activities 7,992 596 (48,421) (15,893)
Financing activities
Payment of debt issuance costs (1,050) - (1,050) -
Net proceeds from exercise of common stock options and employee stock purchases - 415 354 677
Repurchase of shares to satisfy employee tax withholding obligations (1,112) (1,395) (3,413) (3,330)
Principal payments in connection with leases - (5) (4) (38)
Payments of preferred stock dividends (2,821) (2,660) (5,561) (3,533)
Net cash used in financing activities (4,983) (3,645) (9,674) (6,224)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (182) 39 (64) (19)
Net decrease in cash, cash equivalents and restricted cash (24,835) (36,396) (76,525) (28,828)
Cash, cash equivalents and restricted cash at beginning of period 67,122 155,208 118,812 147,640
Cash, cash equivalents and restricted cash at end of period $ 42,287 $ 118,812 $ 42,287 $ 118,812
(in thousands, unaudited)
We evaluate our business performance and manage our operations as two distinct reporting segments Medicare and Employer and Individual ("E I"). The Medicare segment consists primarily of commissions earned as the broker of record from our sale of Medicare-related health insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans, and to a lesser extent, ancillary products sold to our Medicare-eligible beneficiaries, including but not limited to, dental and vision insurance. Our commissions may include certain bonus payments, which are generally based on attaining predetermined target sales levels or other objectives, as determined by the health insurance carriers. The Medicare segment also consists of amounts earned in connection with our advertising program for marketing and other services as well as amounts earned from our non-broker of record fee-based arrangements and our performance of various post-enrollment services for members. The E I segment consists primarily of commissions earned from our sale of individual and family plans ("IFP"), including both qualified and non-qualified, small business health insurance plans and ancillary products sold to our non-Medicare-eligible consumers, including but not limited to, dental, vision and short-term insurance. To a lesser extent, the E I segment includes amounts earned from our online sponsorship program that allows carriers to purchase advertising space in specific markets on our website as well as our technology licensing activities.
We report segment information based on how our chief executive officer, who is our chief operating decision maker ("CODM"), regularly reviews our operating results, allocates resources and makes decisions regarding our business operation in the annual budget and forecasting process along with evaluation of actual performance. Our CODM considers budget-to-actual variances on a monthly basis for our segment performance measures when making decisions about allocating capital and personnel to our segments. These performance measures include total segment revenue and segment gross profit (loss). Prior to the fourth quarter of 2024, we reported our measure of segment profitability as segment profit (loss). Accordingly, prior period amounts have been reclassified to conform to the current period presentation, in all material respects.
Segment gross profit (loss) is calculated as total revenue for the applicable segment less variable marketing and advertising expenses, segment customer care and enrollment expenses ("CC E") and cost of revenue for the applicable segment. Variable marketing and advertising expenses represent costs incurred in member acquisition from our direct marketing and marketing partner channels and exclude fixed overhead costs, such as personnel related costs, consulting expenses and other operating costs allocated to the marketing and advertising department. Segment CC E expenses include expenses we incur in assisting applicants during the enrollment process and exclude operating costs allocated to the CC E department.
The results of our reportable segments are summarized for the periods presented below
Three Months Ended December 31, Year Ended December 31,
2024 2023 % Change 2024 2023 % Change
Medicare
Total revenue $ 305,781 $ 233,680 31 % $ 500,638 $ 406,467 23 %
Variable marketing and advertising (86,091) (78,277) (10) % (157,121) (141,487) (11) %
Medicare CC E (58,659) (52,402) (12) % (150,613) (137,910) (9) %
Cost of revenue (1,151) (644) (79) % (1,396) (1,312) (6) %
Medicare segment gross profit $ 159,880 $ 102,357 56 % $ 191,508 $ 125,758 52 %
Three Months Ended December 31, Year Ended December 31,
2024 2023 % Change 2024 2023 % Change
Employer and Individual
Total revenue $ 9,400 $ 13,982 (33) % $ 31,772 $ 46,404 (32) %
Variable marketing and advertising (1,911) (1,141) (67) % (4,321) (3,304) (31) %
E I CC E (3,371) (3,122) (8) % (10,103) (9,214) (10) %
Cost of revenue (98) (465) 79 % (398) (459) 13 %
E I segment gross profit $ 4,020 $ 9,254 (57) % $ 16,950 $ 33,427 (49) %
(in thousands, unaudited)
Three Months Ended December 31, Year Ended December 31,
2024 2023 % Change 2024 2023 % Change
Consolidated
Total revenue $ 315,181 $ 247,662 27 % $ 532,410 $ 452,871 18 %
Variable marketing and advertising (88,002) (79,418) (11) % (161,442) (144,791) (12) %
Segment CC E (62,030) (55,524) (12) % (160,716) (147,124) (9) %
Cost of revenue (1,249) (1,109) (13) % (1,794) (1,771) (1) %
Total segment gross profit $ 163,900 $ 111,611 47 % $ 208,458 $ 159,185 31 %
A reconciliation of our segment gross profit (loss) to the Condensed Consolidated Statements of Operations for the periods presented is as follows
Three Months Ended December 31, Year Ended December 31,
2024 2023 % Change 2024 2023 % Change
Total segment gross profit $ 163,900 $ 111,611 47 % $ 208,458 $ 159,185 31 %
Other marketing and advertising (1) (8,195) (8,541) 4 % (29,395) (27,849) (6) %
Other CC E (2) (645) (87) * (2,732) (2,438) (12) %
Technology and content (14,907) (16,562) 10 % (53,520) (58,609) 9 %
General and administrative (27,447) (27,053) (1) % (89,765) (99,363) 10 %
Impairment, restructuring and other charges (66) - * (9,475) - *
Interest expense (2,642) (2,852) 7 % (11,159) (10,974) (2) %
Other income, net 475 1,953 (76) % 6,900 9,453 (27) %
Income (loss) before income taxes $ 110,473 $ 58,469 89 % $ 19,312 $ (30,595) 163 %
* Percentage calculated is not meaningful.
(1)Other marketing and advertising costs consist of fixed marketing and advertising, previously capitalized labor, depreciation and share-based compensation costs.
(2)Other CC E costs consist of previously capitalized labor, depreciation and share-based compensation costs.
(in thousands, unaudited)
Our commission revenue results from approval of an application from health insurance carriers, which we define as our customers under Accounting Standards Codification 606 - Revenue from Contracts with Customers ("ASC 606"). Our commission revenue is primarily comprised of commissions from health insurance carriers which is computed using the estimated constrained lifetime values of commission payments that we expect to receive. Our commissions may include certain bonus payments, which are generally based on our attaining predetermined target sales levels or other objectives, as determined by the health insurance carriers.
The following table presents commission revenue by product for the periods indicated
Three Months Ended December 31, % Change Year Ended December 31, % Change
2024 2023 2024 2023
Medicare
Medicare Advantage $ 251,315 $ 192,618 30 % $ 394,942 $ 335,849 18 %
Medicare Supplement 7,799 6,039 29 % 19,634 13,825 42 %
Medicare Part D 6,535 6,494 1 % 12,773 11,180 14 %
Total Medicare 265,649 205,151 29 % 427,349 360,854 18 %
Individual and Family
Non-Qualified Health Plans 1,806 3,736 (52) % 3,640 10,640 (66) %
Qualified Health Plans 1,404 1,936 (27) % 4,762 6,020 (21) %
Total Individual and Family 3,210 5,672 (43) % 8,402 16,660 (50) %
Ancillary 3,508 3,251 8 % 10,787 10,754 - %
Small Business 3,098 5,112 (39) % 11,545 17,669 (35) %
Commission Bonus and Other 186 (690) 127 % 3,564 (2,013) 277 %
Total Commission Revenue $ 275,651 $ 218,496 26 % $ 461,647 $ 403,924 14 %
The following table presents a summary of commission revenue by segment for the periods indicated
Three Months Ended December 31, Year Ended December 31,
2024 2023 2024 2023
Medicare
Commission revenue from members approved during the period $ 260,870 $ 194,295 $ 412,887 $ 326,087
Net commission revenue from members approved in prior periods (a) 5,905 10,798 18,678 33,544
Total Medicare segment commission revenue 266,775 205,093 431,565 359,631
Employer and Individual
Commission revenue from members approved during the period 4,673 5,954 16,463 19,789
Commission revenue from renewals of small business members during the period 2,540 2,674 9,562 9,973
Net commission revenue from members approved in prior periods (a) 1,663 4,775 4,057 14,531
Total Employer and Individual segment commission revenue 8,876 13,403 30,082 44,293
Total commission revenue $ 275,651 $ 218,496 $ 461,647 $ 403,924
(a) These amounts reflect our revised estimates of cash collections for certain members approved prior to the relevant reporting period that are recognized as adjustments to revenue within the relevant reporting period. The net commission revenue from members approved in prior periods, or net adjustment revenue, includes both increases in revenue for certain prior period cohorts as well as reductions in revenue for certain prior period cohorts. The total reductions to revenue from members approved in prior periods were $0.8 million and $0.6 million for the three months ended December 31, 2024 and 2023, respectively, and $5.3 million and $4.3 million for the year ended December 31, 2024 and 2023, respectively. These reductions to revenue primarily relate to the Medicare segment.
SUMMARY OF SELECTED METRICS
(in thousands, except member and per member data, unaudited)
Selected Metrics - Fourth Quarter of 2024
Three Months Ended December 31, % Change
2024 2023
Approved Members (2)(a)
Medicare
Medicare Advantage 222,631 159,595 39 %
Medicare Supplement 4,248 6,868 (38) %
Medicare Part D 21,561 20,104 7 %
Total Medicare 248,440 186,567 33 %
Individual and Family 7,131 9,207 (23) %
Ancillary 15,146 14,205 7 %
Small Business 1,646 2,406 (32) %
Total Approved Members 272,363 212,385 28 %
(a) The shift of some carrier arrangements from broker of record to fee-based BPO during 2024 impacted the growth in approved members as only arrangements where we are broker of record are reflected in approved members.
Constrained Lifetime Value of Commissions per Approved Member (3)
Medicare (b)
Medicare Advantage $ 1,174 $ 1,151 2 %
Medicare Supplement 1,270 931 36 %
Medicare Part D 155 220 (30) %
Individual and Family
Non-Qualified Health Plans 396 400 (1) %
Qualified Health Plans 399 378 6 %
Ancillary
Short-term 108 172 (37) %
Dental 140 117 20 %
Vision 86 83 4 %
Small Business 236 231 2 %
(b) Constraint for Medicare Advantage was 5.5% and 7% for the three months ended December 31, 2024 and 2023, respectively. Constraints for all other Medicare products remained the same for the periods presented.
Expense Metrics per Approved Member (4)
Medicare Plans
Customer care and enrollment cost per Medicare Advantage ("MA")-equivalent approved member (8) $ 220 $ 307 (28) %
Variable marketing cost per MA-equivalent approved member 371 456 (19) %
Total acquisition cost per MA-equivalent approved member $ 591 $ 763 (23) %
Individual and Family Plans ("IFP")
Customer care and enrollment cost per IFP-equivalent approved member (8) $ 288 $ 183 57 %
Variable marketing cost per IFP-equivalent approved member 191 84 127 %
Total acquisition cost per IFP-equivalent approved member $ 479 $ 267 79 %
Note See accompanying footnotes on page 15.
SUMMARY OF SELECTED METRICS
(in thousands, except member and per member data, unaudited)
Selected Metrics - Year Ended December 31, 2024
Year Ended December 31, % Change
2024 2023
Approved Members (2)(a)
Medicare
Medicare Advantage 366,160 290,712 26 %
Medicare Supplement 13,822 17,386 (20) %
Medicare Part D 27,896 29,378 (5) %
Total Medicare 407,878 337,476 21 %
Individual and Family 20,671 27,318 (24) %
Ancillary 51,556 56,789 (9) %
Small Business 5,351 7,613 (30) %
Total Approved Members 485,456 429,196 13 %
(a) The shift of some carrier arrangements from broker of record to fee-based BPO during 2024 impacted the growth in approved members as only arrangements where we are broker of record are reflected in approved members.
As of December 31, % Change
2024 2023
Estimated Membership (5)(b)
Medicare (6)
Medicare Advantage 690,874 622,896 11 %
Medicare Supplement 96,894 110,826 (13) %
Medicare Part D 210,917 210,876 - %
Total Medicare 998,685 944,598 6 %
Individual and Family (6) 78,452 86,452 (9) %
Ancillary (6) 173,760 180,741 (4) %
Small Business (7) 42,899 46,225 (7) %
Total Estimated Membership 1,293,796 1,258,016 3 %
(b) The shift of some carrier arrangements from broker of record to fee-based BPO during 2024 impacted the growth in estimated membership as only arrangements where we are broker of record are reflected in estimated membership.
Note See accompanying footnotes on page 15.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Reconciliation of GAAP Operating Costs and Expenses to Non-GAAP Operating Costs and Expenses(1) (in thousands)
Three Months Ended December 31, Year Ended December 31,
2024 2023 2024 2023
GAAP marketing and advertising expense (8) $ 96,197 $ 87,959 $ 190,837 $ 172,640
Stock-based compensation expense (621) (603) (2,413) (2,201)
Non-GAAP marketing and advertising expense (1) $ 95,576 $ 87,356 $ 188,424 $ 170,439
GAAP customer care and enrollment expense (8) $ 62,675 $ 55,611 $ 163,448 $ 149,562
Stock-based compensation expense (358) (58) (1,845) (2,287)
Non-GAAP customer care and enrollment expense (1) $ 62,317 $ 55,553 $ 161,603 $ 147,275
GAAP technology and content expense (8) $ 14,907 $ 16,562 $ 53,520 $ 58,609
GAAP general and administrative expense (8) 27,447 27,053 89,765 99,363
Technology and content stock-based compensation expense (733) (1,114) (3,331) (4,498)
General and administrative stock-based compensation expense (3,044) (3,697) (12,292) (14,227)
Non-GAAP fixed costs (1) $ 38,577 $ 38,804 $ 127,662 $ 139,247
GAAP operating costs and expenses $ 202,541 $ 188,294 $ 508,839 $ 481,945
Stock-based compensation expense (4,756) (5,472) (19,881) (23,213)
Impairment, restructuring and other charges (66) - (9,475) -
Non-GAAP operating costs and expenses (1) $ 197,719 $ 182,822 $ 479,483 $ 458,732
Reconciliation of GAAP Net Income (Loss) Attributable to Common Stockholders to Adjusted EBITDA(1) (in thousands) and Adjusted EBITDA Margin(1)
Three Months Ended December 31, Year Ended December 31,
2024 2023 2024 2023
GAAP net income (loss) attributable to common stockholders $ 85,687 $ 41,691 $ (34,960) $ (66,515)
Preferred stock dividends 5,646 5,321 22,249 20,965
Change in preferred stock redemption value 6,149 5,178 22,768 17,336
GAAP net income (loss) 97,482 52,190 10,057 (28,214)
Stock-based compensation expense 4,756 5,472 19,881 23,213
Depreciation and amortization 3,827 4,775 16,338 19,916
Impairment, restructuring and other charges 66 - 9,475 -
Interest expense 2,642 2,852 11,159 10,974
Other income, net (475) (1,953) (6,900) (9,453)
Provision for (benefit from) income taxes 12,991 6,279 9,255 (2,381)
Adjusted EBITDA (1) $ 121,289 $ 69,615 $ 69,265 $ 14,055
Net income (loss) margin 31 % 21 % 2 % (6) %
Adjusted EBITDA margin (1) 38 % 28 % 13 % 3 %
Note See accompanying footnotes on page 15.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Reconciliation of GAAP Net Income (Loss) to Non-GAAP Net Income (Loss)(1) and GAAP Net Income (Loss) to Adjusted EBITDA Excluding Net Adjustment Revenue(1) (in thousands)

Frequently Asked Questions

What were eHealth's Q4 2024 total revenues?

eHealth reported total revenues of $315.2 million for Q4 2024.

How much did eHealth's Medicare submissions grow in Q4 2024?

Medicare submissions grew by 38% in Q4 2024 compared to Q4 2023.

What was eHealth's net income for FY 2024?

eHealth achieved a net income of $10.1 million for the fiscal year 2024.

How much is eHealth's commissions receivable balance?

As of December 31, 2024, the commissions receivable balance was $1.0 billion.

What is eHealth's revenue guidance for 2025?

Total revenue for 2025 is expected to range between $510 million and $550 million.

Last updated: Feb 26, 2025